New Enterprise Associates

World's largest venture capital firm with $25B+ AUM and 650+ liquidity events across tech and healthcare

ActiveVenture Capital

Website LinkedIn X

Updated: Dec 3, 2025 ·

About

World's largest venture capital firm with $25B+ AUM and 650+ liquidity events across tech and healthcare

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Feb 12, 2026	Anterior	$40.0M Venture Round	New Enterprise Associates	FPV Ventures, Kinnevik, Sequoia Capital
Feb 10, 2026	AdZen	Seed	Fiat Ventures, Inventus Capital Partners, SVQUAD	Andreessen Horowitz, Bain Capital Ventures
Oct 1, 2025	Affinia Therapeutics	$40.0M Series C	—	Atlas Venture, F-Prime Capital Partners, Ed Mathers
Oct 1, 2025	Uniphore	$260.0M Series F	—	Axilor Ventures, Coatue, March Capital, Hilarie Koplow-McAdams, Scott Sandell, Prosperity7 Ventures, Stata Venture Partners
Oct 1, 2025	Kaizen Labs	$21.0M Series A	—	Accel, Andreessen Horowitz, Andrew Schoen, Seven Seven Six
Oct 1, 2025	CoreStory	$32.0M Series A	—	Aaron Jacobson, Tribeca Venture Partners
Sep 1, 2025	Outsmart Education	$23.0M Seed	—	AirAngels, Khosla Ventures, Sheila Lirio Marcelo, Adam D'Angelo
Sep 1, 2025	Djust	$8.0M Series A	—	Elaia Partners, Philip Chopin, Speedinvest
Sep 1, 2025	CuspAI	$100.0M Series A	—	ARCH Venture Partners, Basis Set Ventures, F-Prime Capital Partners, FTX Ventures, General Catalyst, Hoxton Ventures, Lightspeed Venture Partners, Lux Capital, Mubadala, Brooke Seawell, Northzone, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh, Mandeep Singh, Scott Belsky
Sep 1, 2025	Flox	$25.0M Series B	—	Addition, Afore Capital, Alumni Ventures, Craft Ventures, Harpoon, McCarthy Capital, MizMaa Ventures, Aaron Jacobson, Dan Magnuszewski, Guy Podjarny, Thomas Dohmke
Sep 1, 2025	Zania	$18.0M Series A	—	Andreessen Horowitz, BITKRAFT Ventures, Foundation Capital, Kindred Ventures, LGF, Lightspeed Venture Partners, Ludlow Ventures, Mischief Venture Capital, Hilarie Koplow-McAdams, Scott Sandell, Tet Ventures, The Fintech Fund, Union Square Ventures, Allison Pickens (Allison Pickens Ventures), Charles Zedlewski, Naveen Jain, Neha Narkhede, William Hockey
Sep 1, 2025	Strive Health	$300.0M Series D	—	AIX Ventures, Ascension Ventures, CapitalG, CVS Health, SJF Ventures, Surface Ventures, Akhil Paul, Akshay Sriprasad, Austin Walters, Joanne Bradford, Marc Benioff, Ricardo Marino
Sep 1, 2025	Brale	$30.0M Seed	—	Accel, Acrew Capital, BITKRAFT Ventures, DST Global, Foundation Capital, Founder Collective, Greylock, Illuminate Ventures, Kindred Ventures, Lightspeed Venture Partners, Ludlow Ventures, Jeff Immelt, Scott Sandell, Tenacity Venture Capital, The Fintech Fund, Union Square Ventures, Steve Krausz, Greg Kidd, Kunal Shah, Naveen Jain, Shlomo Kramer
Sep 1, 2025	CHARM Therapeutics	$80.0M Series B	—	Andreessen Horowitz, Bowery Capital, Creandum, EQT Partners, Flex Capital, F-Prime Capital Partners, General Catalyst, Hyperplane Venture Capital, Khosla Ventures, Matthew McAviney, OrbiMed, Silence, Roger Ehrenberg, Shervin Pishevar, Susanna Campbell
Sep 1, 2025	Mojo Vision	$75.0M Series B	—	Flucas Ventures, Fusion Fund, HP Tech Ventures, Greg Papadopoulos, TDK Ventures, VanedgeCapital Partners, Wayne Chang
Aug 1, 2025	Translucent AI	$7.0M Seed	—	TMV
Aug 1, 2025	Elion	$9.0M Seed	—	Alumni Ventures, Arkitekt Ventures, Banana Capital, BBG Ventures, bloom venture partners, General Catalyst, Max Ventures, Lily Huang, Michael Li, OMERS Ventures, StartHer, TMV, Trust Ventures, Bobby Lo
Aug 1, 2025	August	$7.0M Seed	—	Acrew Capital, Coelius Capital, Craft Ventures, ENIAC Ventures, Jenny Fielding, Scott Hartley, Tiffany Luck, Pear VC, Saga, Y Combinator, Arash Ferdowsi, Claire Hughes Johnson, Gokul Rajaram, Surahbi Gupta
Aug 1, 2025	Bluefish Labs	$20.0M Series A	—	Ann Bordetsky, Slack Fund, Trajectory Ventures
Jul 1, 2025	NG.CASH	$27.0M Series B	—	8VC, AIX Ventures, Andreessen Horowitz, General Catalyst, HV Capital, Modern Venture Partners, monashees, NEO, Andrew Schoen, Greg Papadopoulos, Paradigm, TriplePoint Capital, Arash Ferdowsi, Chris Murphy, Daniel Krauss, Dominik Richter, Emmanuel Thomassin, Juan Pablo Ortega, Kaushik Subramanian, Mario Gabriele, Pedro Franceschi
Jul 1, 2025	Genie	$6.0M Seed	—	Antler, Y Combinator
Jul 1, 2025	Firestorm	$35.0M Series A	—	Afore Capital, Alumni Ventures, Craft Ventures, DN Capital, Floodgate, Giant Ventures, Harpoon, IDG Ventures, LAUNCH, McCarthy Capital, Aaron Jacobson, Alexander Rosen, Scout Ventures, SignalFire, Slow Ventures, Y Combinator, Drew Houston, Emmett Shear, Kyle Vogt
Jun 1, 2025	Sitch	$5.0M Seed	—	Lightspeed Venture Partners, M13, Vanessa Larco
Jun 1, 2025	Splice Bio	$140.0M Series B	—	Asabys Partners, EQT Life Sciences, Forbion, Ed Mathers, Novartis Venture Fund, Roche Venture Fund, Sanofi Ventures, Ysios Capital
Jun 1, 2025	Allay Therapeutics	$58.0M Series D	—	Arboretum Ventures, Lightstone Ventures, New Enterprise Associates (NEA), Tak Cheung

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at New Enterprise Associates.

Venture Capital Associate

Life Sciences & Digital Health Startup Investing

Entrepreneur In Residence

Robert Garland

Venture Partner

Patrick Chung

Head of Consumer and Seed investment practices

Hilarie Koplow-McAdams

Venture Capital Investor - Healthcare Team

Principal & Co-Head Seed Practice

Leadership Team

Key people at New Enterprise Associates.

Venture Capital Associate

Life Sciences & Digital Health Startup Investing

Entrepreneur In Residence

Robert Garland

Venture Partner

Patrick Chung

Head of Consumer and Seed investment practices

Hilarie Koplow-McAdams

Venture Capital Investor - Healthcare Team

Principal & Co-Head Seed Practice

Deep Dive

High-Level Overview

New Enterprise Associates (NEA) is one of the world’s largest venture capital firms, managing over $25 billion in assets under management (AUM) and having facilitated more than 650 liquidity events across technology and healthcare sectors. NEA’s mission is to partner with entrepreneurs at every stage of company building, from seed to IPO, providing not only capital but also operational support and strategic guidance. Their investment philosophy centers on deep domain expertise, collaboration, and long-term commitment to founders, aiming to back transformational innovations that create enduring impact. NEA primarily invests in technology and healthcare, focusing on sectors such as artificial intelligence, big data, SaaS, climate tech, and life sciences, thereby significantly shaping the startup ecosystem by enabling breakthrough companies to scale and succeed globally[1][3][6].

Origin Story

NEA was founded in 1977 by C. Richard (Dick) Kramlich, Charles (Chuck) Newhall III, and Frank Bonsal, Jr., each bringing extensive experience in venture capital, investment banking, and fund management. Kramlich had worked with legendary venture capitalist Arthur Rock, Bonsal specialized in IPOs, and Newhall managed investment funds. The firm was established with offices on both the East and West Coasts of the U.S., a unique approach at the time. NEA’s first fund raised $16 million, and one of its earliest investments was in 3Com in 1981. Over the decades, NEA steadily grew its funds, raising progressively larger amounts, including record-breaking funds in the 2010s, such as a $3.3 billion fund in 2017, reflecting its evolution into a global powerhouse in venture capital[1][2][5][6].

Core Differentiators

Unique Investment Model: NEA invests across all stages of company growth, from seed to late-stage, allowing flexibility and long-term partnership with founders.
Network Strength: With decades of experience and a broad portfolio, NEA leverages a vast network of industry experts, entrepreneurs, and co-investors.
Track Record: Over 650 liquidity events and investments in category-defining companies demonstrate a proven ability to identify and scale winners.
Operating Support: NEA actively collaborates with founders, offering hands-on support beyond capital, including strategic advice, recruiting, and navigating market challenges.
Sector Expertise: Deep focus on technology and healthcare enables NEA to provide specialized insights and resources tailored to these complex industries[1][3][6].

Role in the Broader Tech Landscape

NEA rides the wave of rapid technological and healthcare innovation, capitalizing on trends such as AI/ML, big data, SaaS, and biotech advancements. The timing of their growth aligns with increasing global demand for digital transformation and healthcare solutions, supported by favorable market forces like rising startup activity and expanding venture capital ecosystems. NEA’s influence extends beyond funding; by backing foundational technologies and healthcare breakthroughs, they help shape industry standards and accelerate innovation cycles, fostering a more dynamic and interconnected startup ecosystem worldwide[3][6].

Quick Take & Future Outlook

Looking ahead, NEA is poised to continue expanding its influence by investing in frontier technologies and healthcare innovations that address pressing global challenges. Trends such as climate tech, AI-driven healthcare, and data analytics will likely shape their portfolio focus. As the venture capital landscape evolves, NEA’s commitment to deep founder partnerships and operational involvement positions it to remain a key player in nurturing the next generation of transformative companies. Their legacy of enduring support and strategic insight suggests they will keep “daring to disturb the universe” by backing bold entrepreneurs who redefine industries[1][3][6][7].

Sources

High-Level Overview

Origin Story

Core Differentiators

Unique Investment Model: NEA invests across all stages of company growth, from seed to late-stage, allowing flexibility and long-term partnership with founders.
Network Strength: With decades of experience and a broad portfolio, NEA leverages a vast network of industry experts, entrepreneurs, and co-investors.
Track Record: Over 650 liquidity events and investments in category-defining companies demonstrate a proven ability to identify and scale winners.
Operating Support: NEA actively collaborates with founders, offering hands-on support beyond capital, including strategic advice, recruiting, and navigating market challenges.
Sector Expertise: Deep focus on technology and healthcare enables NEA to provide specialized insights and resources tailored to these complex industries[1][3][6].